Aerska
PrivateLast Round
Series A
May 20, 2026
Total Funding Raised
$119M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aerska is a biotechnology company developing RNA interference (RNAi) medicines designed to treat, delay, and prevent diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aerska Comparables
Compare Aerska with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cenos Therapeutics | 87% | |
| CereCura Nanotherapeutics | 80% | |
| Qinotto, Inc. | 79% | |
Aerska Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 20, 2026 | ||||
| Series A | Feb 9, 2026 | ||||
| Seed | Oct 2, 2025 |
Aerska Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A |
| Backed VC | Seed |
| Saras Capital | Seed |
| Lingotto | Seed |
| BlueYard Capital | Seed |
| Ada Ventures | Seed |
| age1 | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 27% QoQ, from 22 to 28 employees.
- Jun 25, 2026
Grew 35% QoQ, from 20 to 27 employees.
Aerska Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aerska's valuation, stock price, and market status.